Radcliffe Capital Management’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,007,063
Closed -$10.1M 1151
2022
Q3
$10.1M Buy
1,007,063
+4,760
+0.5% +$47.3K 0.24% 51
2022
Q2
$9.9M Buy
1,002,303
+197,449
+25% +$1.95M 0.23% 51
2022
Q1
$7.93M Buy
804,854
+628,036
+355% +$6.16M 0.18% 83
2021
Q4
$1.73M Hold
176,818
0.05% 627
2021
Q3
$1.73M Hold
176,818
0.05% 524
2021
Q2
$1.77M Hold
176,818
0.06% 542
2021
Q1
$1.81M Buy
+176,818
New +$2.09M 0.07% 459

Other funds holding HAAC

Radcliffe Capital Management's HAAC Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 1,007,063 shares — an estimated $10.1M sold.

Radcliffe Capital Management first reported a position in HAAC in Q1 2021 and held it in 7 quarters. The position peaked at $10.1M in Q3 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

  • Radcliffe Capital Management reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 1,007,063 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $10.1M.
  • Radcliffe Capital Management first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Radcliffe Capital Management's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $10.1M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.